| BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS (NCT06704152) | BlueSphere Bio, Inc | 2025-02-04 |
| Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets (NCT06289881) | Bio-innova Co., Ltd | 2025-02-04 |
| BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer (NCT06756932) | BeOne Medicines | 2025-02-04 |
| Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers (NCT07181538) | Onconic Therapeutics Inc. | 2025-02-04 |
| A Phase 1 Study of Y-3 in US Healthy Volunteers. (NCT06770491) | Neurodawn Pharmaceutical Co., Ltd. | 2025-02-04 |
| A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy (NCT06247787) | Children's Oncology Group | 2025-02-04 |
| Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets (NCT06801418) | Mirati Therapeutics Inc. | 2025-02-04 |
| A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389 (NCT06812780) | AstraZeneca | 2025-02-04 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors (NCT06618287) | Bristol-Myers Squibb | 2025-02-04 |
| A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults (NCT07117799) | Pfizer | 2025-02-04 |
| A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies (NCT06720987) | Kumquat Biosciences Inc. | 2025-02-04 |
| Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain (NCT06810245) | Contineum Therapeutics | 2025-02-04 |
| Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria (NCT06559618) | Barbara Trautner | 2025-02-03 |
| Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors (NCT06364410) | National Cancer Institute (NCI) | 2025-02-03 |
| To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants (NCT06808802) | Eli Lilly and Company | 2025-02-03 |
| The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi (NCT06836206) | Abu Dhabi Health Services Company | 2025-02-03 |
| A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit (NCT06805825) | Novelty Nobility, Inc. | 2025-02-03 |
| QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma (NCT06822985) | Wan-Guang Zhang | 2025-02-01 |
| Effect of Food and Age on the Pharmacokinetics of LY03017 (NCT06793995) | Luye Pharma Group Ltd. | 2025-02-01 |
| A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity (NCT06817863) | Drexel University | 2025-02-01 |
| Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer (NCT06736717) | University of Kansas Medical Center | 2025-02-01 |
| Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis (NCT07436208) | Zagazig University | 2025-02-01 |
| Assessing the Safety of an IGY Supplement on the Gut Microbiome (NCT06702280) | Nimble Science Ltd. | 2025-02-01 |
| Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma (NCT06845241) | Beijing InnoCare Pharma Tech Co., Ltd. | 2025-02-01 |
| Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass (NCT06917859) | Ain Shams University | 2025-02-01 |
| Phenserine on the Alzheimer's Treatment Horizon, Study 1 (NCT06774261) | Helse Stavanger HF | 2025-02-01 |
| PT150 Drug for Use in Alcohol Use Disorder (NCT06712602) | Pop Test Oncology LLC | 2025-02-01 |
| A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients (NCT06811870) | Guangdong Provincial People's Hospital | 2025-02-01 |
| A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants (NCT06772870) | Design Therapeutics, Inc. | 2025-02-01 |
| Double Dose 4-AP on Functional Recovery After Spinal Cord Injury (NCT06853015) | Shirley Ryan AbilityLab | 2025-02-01 |
| Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV (NCT06139796) | PENTA Foundation | 2025-02-01 |
| Oral Curcumin for the Treatment of Pain of Thumb Base Joint (CMC) Arthritis (NCT06359665) | Brent DeGeorge | 2025-02-01 |
| Efficacy of UMT in CG Patients With PL (NCT07530627) | Peking University First Hospital | 2025-02-01 |
| Study of JMKX003948 Ophthalmic Suspension in Healthy Participants (NCT06832657) | Jemincare | 2025-02-01 |
| The Effect of High Single Dose of Dexamethasone in Prevention of Post-operative Acute Kidney Injury in Cardiac Surgeries Requiring Cardiopulmonary Bypass (NCT06783634) | Ain Shams University | 2025-02-01 |
| Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis (NCT06793514) | Mohsen Pourazizi | 2025-02-01 |
| ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19) (NCT05433181) | University of Pennsylvania | 2025-02-01 |
| A Study of SCTB35 in Patients with Systemic Lupus Erythematosus (NCT06841042) | Sinocelltech Ltd. | 2025-02-01 |
| Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes (NCT05689424) | University of California, San Diego | 2025-02-01 |
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases (NCT06888973) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2025-02-01 |
| PRF vs. Graftless Sinus Lift With Implant Placement (NCT07090694) | Dar Al Uloom University | 2025-02-01 |
| A Study of AK-1286 in Patients With Advanced Solid Tumors (NCT06779045) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2025-02-01 |
| Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma (NCT07477912) | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 2025-02-01 |
| Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants (NCT06830954) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2025-02-01 |
| Regulation of Emotion, Sleep Extension, and mTBI (NCT06883006) | Merrimack College | 2025-02-01 |
| A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma (NCT06799676) | Fuling Zhou | 2025-02-01 |
| A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer (NCT06545617) | Bio-Thera Solutions | 2025-01-31 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants (NCT06740474) | Assembly Biosciences | 2025-01-31 |
| Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms (NCT06284460) | M.D. Anderson Cancer Center | 2025-01-31 |
| A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects (NCT06802185) | HALEON | 2025-01-31 |
| Evaluation Study of New Compounds With Potential Use in Schizophrenia (NCT00916201) | Central Institute of Mental Health, Mannheim | 2025-01-31 |
| A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma (NCT06799026) | David Avigan | 2025-01-31 |
| A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity (NCT06842186) | Wave Life Sciences USA, Inc. | 2025-01-31 |
| A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired Hepatic Function (NCT06734208) | Genentech, Inc. | 2025-01-31 |
| Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma (NCT06803875) | Roberto Chiarle | 2025-01-31 |
| A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma (NCT06672575) | M.D. Anderson Cancer Center | 2025-01-30 |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies (NCT06564038) | AstraZeneca | 2025-01-30 |
| Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis (NCT06374459) | Washington University School of Medicine | 2025-01-30 |
| A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome) (NCT06616636) | M.D. Anderson Cancer Center | 2025-01-30 |
| A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled Diranersen (BIIB080) Co-administered With Diranersen in Healthy Adults (NCT06454721) | Biogen | 2025-01-30 |
| Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment (NCT06611007) | University Hospital, Grenoble | 2025-01-30 |
| Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D (NCT06829563) | Rezubio Pharmaceuticals Co., Ltd. | 2025-01-30 |
| Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) (NCT06710132) | EMD Serono Research & Development Institute, Inc. | 2025-01-29 |
| Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations (NCT06655649) | Johns Hopkins University | 2025-01-29 |
| A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump (NCT06809621) | Novo Nordisk A/S | 2025-01-29 |
| A Study of Sotorasib in People With Brain Tumors (NCT06807619) | Memorial Sloan Kettering Cancer Center | 2025-01-29 |
| A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects. (NCT06929052) | Kashiv BioSciences, LLC | 2025-01-29 |
| A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors (NCT06771921) | Genmab | 2025-01-29 |
| A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer (NCT06807632) | Memorial Sloan Kettering Cancer Center | 2025-01-29 |
| Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma (NCT06485947) | Princess Maxima Center for Pediatric Oncology | 2025-01-28 |
| Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients (NCT07724873) | Tata Memorial Centre | 2025-01-28 |
| Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause (NCT06806345) | Cairo University | 2025-01-28 |
| Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant (NCT06498973) | City of Hope Medical Center | 2025-01-28 |
| Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease (NCT06754891) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-01-28 |
| A Mass Balance Study Following Subcutaneous Administration of [14C]-ITI-1284 to Healthy Male Subjects (NCT06786286) | Intra-Cellular Therapies, Inc. | 2025-01-28 |
| A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma (NCT06795906) | AstraZeneca | 2025-01-28 |
| A Study of Atorvo+™ in Healthy Adult Participants (NCT06615284) | Indication Bioscience LLC | 2025-01-28 |
| A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (NCT06291220) | AbbVie | 2025-01-27 |
| A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine (NCT06628622) | Boehringer Ingelheim | 2025-01-27 |
| Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) (NCT06665724) | Universität Münster | 2025-01-27 |
| Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas (NCT06709495) | David S Shulman, MD | 2025-01-27 |
| The ENHANCE Study: taVNS and Psilocybin (NCT05866471) | University of Wisconsin, Madison | 2025-01-27 |
| Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets (NCT06606860) | Swiss Tropical & Public Health Institute | 2025-01-27 |
| RENEW-SHCS: Safety and Immunogenicity of a Recombinant HIV Env Protein Vaccine in ARV-treated Adults Living With HIV in the SHCS (NCT07769983) | University of Zurich | 2025-01-27 |
| A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP) (NCT06842121) | Baxter Healthcare Corporation | 2025-01-27 |
| A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E (NCT06842134) | Baxter Healthcare Corporation | 2025-01-27 |
| ALN-APOC3 in Adult Participants With Dyslipidemia (NCT06784349) | Regeneron Pharmaceuticals | 2025-01-27 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. (NCT06847464) | Enanta Pharmaceuticals, Inc | 2025-01-27 |
| Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML (NCT06757855) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-26 |
| Bioequivalence Study Comparing Two Pomalidomide 4 mg Capsule Formulations in Healthy Male Subjects (NCT07694011) | Knight Therapeutics (USA) Inc | 2025-01-25 |
| Effects of Neostigmine-dose on Diaphragmatic Dynamics (NCT06787638) | Aswan University Hospital | 2025-01-25 |
| Impact of Adding Dexmedetomidine as an Adjuvant to The Local Anesthetic in Quadratus Lumborum Block in Patient Undergoing Caesarean Section (NCT07072650) | Majid Fakhir Mutar Alhamaaidah | 2025-01-25 |
| Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors (NCT06781983) | Innate Pharma | 2025-01-24 |
| Evaluating the Efficacy of Platelet-Rich-Plasma (PRP) for Erectile Dysfunction (NCT06264635) | University of Manitoba | 2025-01-24 |
| A Study of SER-155 to Treat Diarrhea in People on Immunotherapy (NCT06801067) | Memorial Sloan Kettering Cancer Center | 2025-01-24 |
| A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants (NCT06776679) | BeiGene | 2025-01-24 |
| COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty (NCT06809998) | Unity Health Toronto | 2025-01-24 |
| Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease (NCT05067595) | Fred Hutchinson Cancer Center | 2025-01-24 |
| A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors (NCT06789172) | Epkin | 2025-01-23 |
| A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body (NCT06791187) | Boehringer Ingelheim | 2025-01-23 |